Evidence map›Paper›PMID 29511610›Full record

ArticleFEBS open bio2018

Aberrant

Hong Yan, Rui Tian, Wei Wang, Min Zhang, Jing Wu, Jie He

Abstract read
In one paragraph

Article in FEBS open bio, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hong YanDepartment of Pathology Anhui Provincial Hospital affiliated to Anhui Medical University and Anhui Provincial Cancer Hospital Hefei China.
Rui TianDepartment of Pathology Anhui Provincial Hospital affiliated to Anhui Medical University and Anhui Provincial Cancer Hospital Hefei China.
Wei WangDepartment of Medical Oncology Anhui Provincial Hospital affiliated to Anhui Medical University Hefei China.
Min ZhangDepartment of Pathology Anhui Provincial Hospital affiliated to Anhui Medical University and Anhui Provincial Cancer Hospital Hefei China.
Jing WuDepartment of Pathology Anhui Provincial Hospital affiliated to Anhui Medical University and Anhui Provincial Cancer Hospital Hefei China.
Jie HeDepartment of Pathology Anhui Provincial Hospital affiliated to Anhui Medical University and Anhui Provincial Cancer Hospital Hefei China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ki-67 (MKI67) is a marker of cellular proliferation of cancer. Here, we show that Ki-67 is post-transcriptionally regulated through alternative polyadenylation (APA) and microRNAs in breast cancer. We show that shortening of the

Indexed as

3′UTRalternative polyadenylationbreast cancerKi‐67miR‐140‐3p

Identifiers

PMID29511610
PMCPMC5832968

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.